PaxGenBio Co., Ltd. was established in 2015 as a molecular diagnostics company that develops, manufactures, and markets a portfolio of IVD products targeting infectious diseases and cancers, and these followings are our main area of business:

- The Proprietary Patented Technology called MPCR ULFA(Multiplex PCR-Universal Lateral Flow Assay) Platform Technology

- Sale of diagnostic products for various infectious diseases (Coronavirus disease (COVID-19), Tuberculosis, HPV, STD, etc.

View catalog

The PaxView® COVID-19 real-time RT-PCR Kit detects the novel coronavirus, COVID-19 using one-step real-time RT-PCR in a single tube.

[Domestic/International Authorization]

MFDS approval, CE-IVD

[Features and Advantages]

One-step PCR in a single tube

real-time RT-PCR

Target genes: Orf1ab(RdRp) and N gene

Monitor the entire process including the sample collection, RNA extraction, and RT-PCR through using internal control, Human Rnase P gene

User-friendly & Simple method

High sensitivity and specificity